Skip to main content
MRK
NYSE Life Sciences

默克预计全年调整后每股收益介于 5.04 美元和 5.16 美元之间

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
8
Price
$112.943
Mkt Cap
$274.033B
52W Low
$73.31
52W High
$125.14
Market data snapshot near publication time

summarizeSummary

默克发布了全年调整后每股收益(EPS)指导,预计范围为 5.04 美元至 5.16 美元。这一财务展望对投资者来说是一项关键信息,直接表明了公司未来一年预期的盈利能力。这一指导是在一系列重大产品开发新闻之后发布的,包括 Keytruda 获得 FDA 优先审查、实验性肾癌治疗药物遭遇挫折,以及获得 FDA 批准的 HIV 治疗方案,以及 Terns Pharmaceuticals 收购进展。交易者将仔细分析这一指导与当前分析师一致预期相比,以确定其对股价的影响,并相应地调整他们的投资论点。市场的反应将取决于这一范围是否满足、超过或低于预期。

在该公告发布时,MRK的交易价格为$112.94,交易所为NYSE,所属行业为Life Sciences,市值约为$2740.3亿。 52周交易区间为$73.31至$125.14。 这则新闻被评估为中性市场情绪,重要性评分为8/10。 来源:Dow Jones Newswires。


show_chartPrice Chart

Share this article

Copied!

feed MRK - Latest Insights

MRK
Apr 30, 2026, 6:53 AM EDT
Filing Type: 8-K
Importance Score:
8
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Reuters
Importance Score:
9
MRK
Apr 30, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
MRK
Apr 24, 2026, 6:45 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
MRK
Apr 21, 2026, 11:50 AM EDT
Source: Reuters
Importance Score:
8
MRK
Apr 21, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
MRK
Apr 20, 2026, 7:29 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
MRK
Apr 13, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
MRK
Apr 08, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MRK
Mar 30, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
9